[Featured Stock] Ildong Pharmaceutical Rises 20% on News of Antigen Test Kit Distribution
[Asia Economy Reporter Myung-hwan Lee] Ildong Pharmaceutical is soaring on news that it has signed a supply contract for antigen test kits.
As of 1 PM on the 7th, Ildong Pharmaceutical is trading at 45,450 KRW, up 22.18% from the previous trading day. Trading volume has also surged, breaking the highest volume record in the past five days.
On the same day in the morning, Ildong Pharmaceutical announced that it had signed a supply contract with Rapigen for the 'BioCredit COVID-19 Ag.' The BioCredit COVID-19 Ag is a professional-use COVID-19 antigen test kit developed by Rapigen. It is a kit that can detect COVID-19 infection using a nasopharyngeal smear specimen collected deep inside the nasal cavity, and test results can be confirmed within 15 to 30 minutes.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Ildong Pharmaceutical stated that it will hold additional discussions regarding the distribution of Rapigen's self-test kits to pharmacies and other outlets.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
